Pancreatic cancer from bench to bedside: molecular pathways and treatment options

In the last forty years the pancreatic cancer treatment has made advances, however; still novel drugs are needed. It is known that the five year survival rate remains around 5%. The best treatment option still remains surgery, if patients are diagnosed early. In the last decade the biology of pancre...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Transl Med
Egile Nagusiak: Kosmidis, Christoforos, Sapalidis, Konstantinos, Kotidis, Efstathios, Mixalopoulos, Nikolaos, Zarogoulidis, Paul, Tsavlis, Drosos, Baka, Sofia, Man, Yan-Gao, Kanellos, John
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2016
Gaiak:
Focus on Surgical Techniques from Bench to Bedside
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876273/
https://ncbi.nlm.nih.gov/pubmed/27275478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.05.11
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak